1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Zhejiang Tianyu Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    300702   CNE1000034X1

ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.

(300702)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zhejiang Tianyu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 900 million in funding

06/22/2020 EDT

Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702) announced a private placement of 13,000,000 common shares for gross proceeds of not more than CNY 900,000,000 on June 22, 2020. The transaction will include participation from not more than 35 specific investors. The shares issue price will not be lower than 80% of the median market price of the company's shares as of 20 previous days to issuance date. The transaction has been approved at the first meeting of the company's fourth board of directors. The transaction is subject to shareholder's approval and has been approved by Shenzhen Stock Exchange and China Securities Regulatory Commission. The shares have a lock-up period of 6 months since issuance date. On July 21, 2020, the Shenzhen Stock Exchange has reviewed and decided to accept the application documents (Acceptance No. 430) submitted by the company. On November 6, 2020, the company announced that the application for approval of the transaction has been accepted by the China Securities Regulatory Commission.


© S&P Capital IQ 2020
All news about ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
05/16Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Final Cash Dividend for 2021
CI
04/22Zhejiang Tianyu Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021
CI
04/21Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter..
CI
04/20MagicRNA announced that it has received $1.57 million in funding from Zhejiang Tianyu P..
CI
2021Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2021Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces 2020 Final Profit Distribution Plan ..
CI
2021ZHEJIANG TIANYU PHARMACEUTICAL : Pharma to List Over 1 Million Restricted Shares
MT
2021Zhejiang Tianyu Pharmaceutical Co., Ltd. Approves Cash Dividend for the 2020
CI
2021Zhejiang Tianyu Pharmaceutical Co., Ltd. Proposes Final Dividend for 2020
CI
More news
Financials
Sales 2022 3 301 M 493 M 493 M
Net income 2022 461 M 68,8 M 68,8 M
Net Debt 2022 - - -
P/E ratio 2022 28,5x
Yield 2022 0,61%
Capitalization 13 143 M 1 962 M 1 962 M
Capi. / Sales 2022 3,98x
Capi. / Sales 2023 3,18x
Nbr of Employees 4 991
Free-Float 37,6%
Chart ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
Duration : Period :
Zhejiang Tianyu Pharmaceutical Co., Ltd. Technical Analysis Chart | 300702 | CNE1000034X1 | MarketScreener
Technical analysis trends ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 37,77 CNY
Average target price 41,47 CNY
Spread / Average Target 9,80%
EPS Revisions
Managers and Directors
Yong Jun Tu Chairman & General Manager
Yan Wang Chief Financial Officer & Board Secretary
Cheng Ma Chairman-Supervisory Board
Hai Zhi Ren Independent Director
Ji Yuan Shi Independent Director